SCREEN-WELL® Compound Libraries complement our wide range of small molecules

Enzo Life Sciences has a long and successful track record in identifying, synthesizing and commercializing known bioactives for use as research tool compounds and in assembling relevant sets of focused compounds for screening.

Our long-standing, flagship SCREEN-WELL® Compound Library product family offers an easy, ready-to-use alternative for compound screening. Each library includes:

• A unique collection of small molecules including inhibitors, activators and/or inducers.
• Complete documentation set that highlights activity descriptions, plate positions, physical information and a structural database (SD) file
• The ability to re-supply individual bulk compounds, custom libraries, or hard to source compounds

Extensive Offering

• A unique offering of focused compound libraries comprised of FDA-approved compounds, natural products, compounds for receptor de-orphaning, chemical genomics, and pathway targeting.
• Current catalog of over 2500 stand-alone small molecules including natural products, enzyme inhibitors, receptor ligands, drugs, lipids & fatty acids etc.

SCREEN-WELL® libraries from Enzo Life Sciences for nephrotoxicity, cardiotoxicity, hepatotoxicity, and hematopoietic toxicity contain compounds with defined and diverse organ-associated toxicity profiles. A variety of structurally and mechanistically different compound classes are included, as well as nontoxic controls. Compounds are dissolved in DMSO at 10mM and aliquoted into deep-well plates at 100 or 500μl per well. The libraries are useful for predictive toxicology screening, including high-content protocols using cell based assays for early safety assessment.

• Hundreds of compounds of defined and diverse toxicity
• Nontoxic controls also included
• Dissolved in DMSO and supplied in 96 well plates so they are ready to screen